Villota, Jovelyn L.
HRN: 22-25-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 1.5GM (VIAL)
11/26/2022
11/27/2022
IVT
1.5g
Q8
S/P NSD; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes